Literature DB >> 16675218

Cyclin D1 and breast cancer.

Pankaj G Roy1, Alastair M Thompson.   

Abstract

Cyclin D1 is one of the frequently overexpressed proteins and one of the commonly amplified genes in breast cancer. This article reviews the roles of cyclin D1 in cell-cycle regulation (normal and abnormal), mammary gland development and carcinogenesis and the relationship to oestrogen in breast tissues. It concludes by presenting the clinical, prognostic and therapeutic implications of our current knowledge of cyclin D1 in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16675218     DOI: 10.1016/j.breast.2006.02.005

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  92 in total

Review 1.  Signal transduction in transgenic mouse models of human breast cancer--implications for human breast cancer.

Authors:  Richard Marcotte; William J Muller
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-24       Impact factor: 2.673

Review 2.  Cyclin D as a therapeutic target in cancer.

Authors:  Elizabeth A Musgrove; C Elizabeth Caldon; Jane Barraclough; Andrew Stone; Robert L Sutherland
Journal:  Nat Rev Cancer       Date:  2011-07-07       Impact factor: 60.716

Review 3.  Oestrogen receptor beta is involved in the actions of oestrogens in the brain for affective behaviour, but not trophic effects in peripheral tissues.

Authors:  A A Walf
Journal:  J Neuroendocrinol       Date:  2009-12-15       Impact factor: 3.627

4.  Coordinated expression of cyclin-dependent kinase-4 and its regulators in human oral tumors.

Authors:  Ming J Poi; Thomas J Knobloch; Marta T Sears; Lana K Uhrig; Blake M Warner; Christopher M Weghorst; Junan Li
Journal:  Anticancer Res       Date:  2014-07       Impact factor: 2.480

5.  Cell-specific Kaiso (ZBTB33) Regulation of Cell Cycle through Cyclin D1 and Cyclin E1.

Authors:  Amir Pozner; Tommy W Terooatea; Bethany A Buck-Koehntop
Journal:  J Biol Chem       Date:  2016-09-30       Impact factor: 5.157

6.  RNA sequencing of MCF-7 breast cancer cells identifies novel estrogen-responsive genes with functional estrogen receptor-binding sites in the vicinity of their transcription start sites.

Authors:  Ryonosuke Yamaga; Kazuhiro Ikeda; Kuniko Horie-Inoue; Yasuyoshi Ouchi; Yutaka Suzuki; Satoshi Inoue
Journal:  Horm Cancer       Date:  2013-03-23       Impact factor: 3.869

7.  Diazoxide-mediated growth inhibition in human lung cancer cells via downregulation of beta-catenin-mediated cyclin D1 transcription.

Authors:  Jianyong Ding; Di Ge; Weigang Guo; Chunlai Lu
Journal:  Lung       Date:  2008-12-04       Impact factor: 2.584

8.  Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression.

Authors:  Junling Si; Xueyan Yu; Yingjie Zhang; James W DeWille
Journal:  Mol Cancer       Date:  2010-04-28       Impact factor: 27.401

9.  Circadian rhythm and its role in malignancy.

Authors:  Sobia Rana; Saqib Mahmood
Journal:  J Circadian Rhythms       Date:  2010-03-31

10.  Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factors.

Authors:  Pia Boström; Mirva Söderström; Tuire Palokangas; Tero Vahlberg; Yrjö Collan; Olli Carpen; Pirkko Hirsimäki
Journal:  BMC Res Notes       Date:  2009-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.